Sheryl McDiarmid
Overview
Explore the profile of Sheryl McDiarmid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan X, Maltez M, Mallick R, Hamelin L, McDiarmid S, Cieniak C, et al.
Eur J Haematol
. 2024 Oct;
114(2):276-284.
PMID: 39445482
Background: Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated remarkable efficacy in relapsed or refractory large B cell lymphoma, but real-world evidence is needed to confirm safety and efficacy when...
2.
Kekre N, Hay K, Webb J, Mallick R, Balasundaram M, Sigrist M, et al.
Front Immunol
. 2023 Jan;
13:1074740.
PMID: 36601119
Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03765177, identifier NCT03765177.
3.
Chruscinski A, Juvet S, Moshkelgosha S, Renner E, Lilly L, Selzner N, et al.
Transplantation
. 2021 May;
106(3):562-574.
PMID: 34049362
Background: Primary sclerosing cholangitis (PSC) is an indication for liver transplantation, but recurrence after liver transplantation is associated with poor outcomes often requiring repeat transplantation. We investigated whether autologous hematopoietic...
4.
Masson-Roy J, Breiner A, Warman-Chardon J, Pringle C, Allan D, Bredeson C, et al.
Can J Neurol Sci
. 2021 Feb;
48(6):760-766.
PMID: 33631093
Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) refractory to conventional therapy can lead to marked disability and represents a therapeutic challenge. Objective: To report five cases of treatment-refractory disabling CIDP treated...
5.
McDiarmid S, Larocque G
Br J Nurs
. 2020 Jul;
29(14):S32-S38.
PMID: 32697632
Breast cancer management is a rapidly evolving field. Diagnosis and treatment options have changed dramatically over the years, as have options for vascular access devices used to administer therapies. We...
6.
Larocque G, McDiarmid S
Can Oncol Nurs J
. 2020 Jan;
29(3):194-203.
PMID: 31966004
Breast cancer is the most common cancer in women. Breast cancer related lymphedema (BCRL) is a chronic condition characterized by an abnormal accumulation of protein-rich fluid in tissues resulting in...
7.
Thornton C, Dumanski J, Margherit C, Vaz-Gonsalves S, McDiarmid S, Parkins M, et al.
Infect Control Hosp Epidemiol
. 2019 Oct;
40(11):1215-1221.
PMID: 31591954
Objective: Peripherally inserted central catheters (PICCs) are a mainstay of nonpermanent vascular access devices. In this study, we assessed patients displaying anaphylaxis or anaphylactoid reactions to the PowerPICC SOLO and...
8.
Scrivens N, Sabri E, Bredeson C, McDiarmid S
Leuk Lymphoma
. 2019 Aug;
61(1):156-164.
PMID: 31387422
Patients with hematological malignancies (HM) or undergoing hematopoietic cell transplantation (HCT) require reliable vascular access. Peripherally inserted central catheters (PICC) meet this need, however, studies suggest these patients have higher...
9.
Suleman A, Jarvis V, Hadziomerovic A, Carrier M, McDiarmid S
Thromb Res
. 2019 Mar;
177:117-121.
PMID: 30875491
Background: Implanted vascular access devices (IVADs) have significantly improved the management of cancer patients. These patients are at an increased risk of venous thromboembolism and IVADs are a known risk...
10.
Robinson A, Souied O, Bota A, LeVasseur N, Stober C, Hilton J, et al.
Breast Cancer Res Treat
. 2018 Jul;
171(3):607-620.
PMID: 29974358
Importance: Systemic chemotherapy can be administered either through a peripheral vein (IV), or centrally through peripherally inserted central catheter (PICC), totally implanted vascular access devices (PORTs) or tunnelled cuffed catheters....